- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04181632
Evaluation of Pain Alleviating Strategies During Allergy Shots (PPAST)
Evaluation of Pain Alleviating Strategies During Allergy Shots (Subcutaneous Immunotherapy): A Randomized Controlled Study (Pain Perception With Allergy Shot Techniques: PPAST)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a randomized controlled study. Approximately 100 children, age 4 - 17 years, who are currently receiving subcutaneous immunotherapy, will randomly select a blinded envelope which assigns the distraction technique to be utilized during their study participation. There will be 25 envelopes assigned to each study group for a total of 100 envelopes. Each envelope will contain a paper with a colored sticker for the associated group assignment and number sequence.
The distribution of group assignment by number sequence and color is as follows:
Interventional Groups
- Shot Blocker® Number 1-25 (RED)
- Buzzy I® (vibrating only) Number 26-50 (GREEN)
- Buzzy II® (vibrating and ice wings) Number 51-75 (BLUE) Control Group
- Ethyl Chloride/Pain Ease Spray Number 76-100 (YELLOW)
The three interventional groups are currently marketed distraction devices. The control group is the current clinical standard of care option for pre-allergy injection application.
The study consists of two visits. Both visits will be conducted during the participants routine clinic visit for allergy injections. At the first visit the investigator will assess eligibility. An overview of the study requirements will be provided to parent/child and consent/assent will be obtained.
During the second visit, the child will be randomized to a distraction technique or standard of care group to be utilized with the allergy injection(s) administered at this visit. Adherence with institutional allergy injection guidelines will be maintained. Prior to the application of the distraction method, the investigator will interview the parent to collect data related to demographic information and their child's current allergy health and treatment regime. The child's pain perception will be assessed before and after the allergy injection. The parent's perception of their child's pain will be assessed after the allergy injection. The investigator will provide information on the application of the randomized method and will provide instruction on the completion of the pain scales and questionnaires. The investigator and study staff will not indicate a method preference or guide the child or parent with their pain level responses. After completion of the second visit, the child's study participation is complete.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Jacksonville, Florida, United States, 32207
- Nemours
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Children aged 4-17 years on injection immunotherapy
- A minimum of three allergy injection injections prior to enrollment at Visit 1
- Child accompanied by parent or legal guardian
Exclusion Criteria:
- Children with a known pain or sensory disorders
- Developmental delays lacking necessary cognitive ability
- Administration of any form of pain analgesic within eight hours of randomization at Visit 2
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Shot Blocker
The three interventional groups are currently marketed distraction devices.
Arm 1 will be Shot Blocker® Number 1-25 (RED).
|
Shot Blocker is a device that instantly alleviates the pain and anxiety of needle injections when pressed firmly against the skin at the injection site.
|
No Intervention: Control Group
The control group is the current clinical standard of care option for pre-allergy injection application.
Ethyl Chloride/Pain Ease Spray Number 76-100 (YELLOW).
|
|
Active Comparator: Buzzy I
The three interventional groups are currently marketed distraction devices.
Arm 2 will be Buzzy® I (vibrating only) Number 26-50 (GREEN).
|
Buzzy uses natural pain relief to block needle pain for blood draws and shots.
This intervention will be used without an ice pack.
|
Active Comparator: Buzzy II
The three interventional groups are currently marketed distraction devices.
Arm 3 will be Buzzy® II (vibrating and ice wings) Number 51-75 (BLUE).
|
Buzzy uses natural pain relief to block needle pain for blood draws and shots.
This intervention will be used with an ice pack.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Patient Pain Perception Utilizing Three Non-pharmacological Pain Control / Distraction Devices and Ethyl Chloride Spray
Time Frame: Assessment of pain perception before and within 1 minute after the application of the distraction method and administration of the allergy injection within their 30-minute allergy shot appointment.
|
The change in patient pain perception will be captured utilizing the Wong-Baker FACES (actual faces of happiness or sadness etc. on the scale) Pain Rating Scale (0 no pain - 10 most pain) with each distraction method.
The lower score is the better outcome.
|
Assessment of pain perception before and within 1 minute after the application of the distraction method and administration of the allergy injection within their 30-minute allergy shot appointment.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1353562
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Allergy
-
University of RochesterNational Institute of Allergy and Infectious Diseases (NIAID)Not yet recruitingEgg Allergy | Food Allergy Peanut | Food Allergy in Infants | Allergy and Immunology | Peanut and Nut AllergyUnited States
-
Hong Kong Sanatorium & HospitalChinese University of Hong KongTerminatedAllergy to Fish | Allergy to Shrimp | Allergy to CrabHong Kong
-
Abionic SAJohns Hopkins University; NAMSAWithdrawnAllergy | Allergic Asthma | Allergy to Cats | Allergy to House Dust | Allergy Cockroach | Allergy to Dog Dander (Finding) | Allergy MoldUnited States
-
King's College LondonGuy's and St Thomas' NHS Foundation TrustUnknownEgg Allergy | Food Allergy | Food Allergy in Children | Milk Allergy | Food Allergy in Infants | Nut Allergy | Food Allergen SensitisationUnited Kingdom
-
Peking University Third HospitalCancer Institute and Hospital, Chinese Academy of Medical Sciences; Beijing... and other collaboratorsRecruitingCow Milk Allergy | Food Allergy in ChildrenChina
-
King's College LondonKing's College Hospital NHS Trust; University College London Hospitals; Cambridge... and other collaboratorsRecruitingEgg Allergy | Food Allergy | Food Allergy in Children | Milk Allergy | Food Allergy in Infants | Nut Allergy | Food Allergen SensitisationUnited Kingdom
-
Chinese University of Hong KongRecruiting
-
Vilnius UniversityEnrolling by invitationFood Allergy in Children | Food Allergy in InfantsLithuania
-
Martini Hospital GroningenRecruitingCow Milk Allergy | Food AllergyNetherlands
-
University GhentActive, not recruitingCow Milk Allergy | Food AllergyBelgium
Clinical Trials on Shot Blocker
-
Tarsus UniversityCompletedEmergencies | Pain, Acute | Fear | Child, Only | Injection FearTurkey
-
Bangor UniversityCompleted
-
Biotronik SE & Co. KGCompletedVentricular Tachycardia, MonomorphicAustria, Finland, Germany, Israel
-
Imam Abdulrahman Bin Faisal UniversityCompletedOne Lung Ventilation | Elective Thoracic SurgerySaudi Arabia
-
University Health Network, TorontoCompletedThoracic Surgery, Lung IsolationCanada
-
Istanbul UniversityNot yet recruiting
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...CompletedSupraspinatus TendinitisItaly
-
Seoul National University HospitalCompletedOne-lung VentilationKorea, Republic of
-
PepsiCo Global R&DCompleted
-
Cairo UniversityNot yet recruiting